Clinical Trial Search

Primary: Number of Participants With Progression of Radio Therapy Induced Skin Reaction — 35; 33 Participants

Primary: Number Of Participants With Adverse Events (AEs), Serious Adverse Events (SAE's) And Withdrawals Due to AE's — 5; 6; 2; 4 Participants

Primary: Glucose Levels Percent Time in Target Range Based on Glucose Monitoring — 61.185; 64.542; 62.223; 64.571 percentage of time-in-range — p=0.777

Primary: Change in Pain Units on a Scale (0-10) 0 Being Least, 10 Being Worst Pain (Value at 8 Weeks Minus Value at Baseline). — -3.7; -3.02; -1.61 units on a scale

Primary: Feasibility of Intervention Completion — 33 Participants

Primary: Retention — 16 Participants

Primary: Evaluate Feasibility of Enrolling and Consenting Greater Than 50% of Eligible Patients — 30 Participants

Primary: Negative Affect — 1.43; 1.29 score on a scale — p=.007

Primary: Pain After TKA Measured by VAS Pain Survey on Focusmotion App — 2.8; 2.6 score on a scale

Primary: Change in Montgomery Åsberg Depression Rating Scale (MADRS) Total Score From Baseline to Day 42, in DGM4-positive Patients — -15.4; -15.5; -15.4; -11.0 Units on a Scale…

Primary: Number of Participants Reporting to Breastfeed — 13; 5 Participants

Primary: Objective Response Rate (ORR) Per Blinded Independent Central Review (BICR) by Revised Response Criteria for Malignant Lymphoma Criteria (Cheson 2007) by Central CD30…

Primary: Number of Subjects Experiencing TEAEs — 16; 12; 9; 2 Participants

Primary: Percent Change in Maximal Inspiratory Pressure (MIP) — 0.3; -3.1; -4.8; -5.0 percentage change in MIP from baseline

Primary: Change From Baseline to Post Training in Hamilton Rating Scale for Depression — -2.75; -7.5; -7.83; -2.29 units on a scale